Abliva AB (publ)

NEVPF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue$137$31$151
% Growth341.9%-79.5%
Cost of Goods Sold$68,819$84,936$32,509
Gross Profit-$68,682-$84,905-$32,358
% Margin-50,132.8%-273,887.1%-21,429.1%
R&D Expenses$53,638$58,884$90,690
G&A Expenses$0$0$0
SG&A Expenses-$25,772$14,028$16,844
Sales & Mktg Exp.$0$0$0
Other Operating Expenses$0$84,936$123,303
Operating Expenses$27,866$84,936$123,303
Operating Income-$96,548-$83,190-$123,482
% Margin-70,473%-268,354.8%-81,776.2%
Other Income/Exp. Net$1,030-$2,074-$12
Pre-Tax Income-$95,518-$85,264-$123,494
Tax Expense-$9$0$4
Net Income-$95,509-$84,964-$123,498
% Margin-69,714.6%-274,077.4%-81,786.8%
EPS-0.09-0.11-0.33
% Growth17.8%66.7%
EPS Diluted-0.09-0.11-0.33
Weighted Avg Shares Out1,056,305739,487379,365
Weighted Avg Shares Out Dil1,056,299739,487379,365
Supplemental Information
Interest Income$1,072$392$0
Interest Expense$76$2,764$12
Depreciation & Amortization$1,834$2,610$2,660
EBITDA-$93,608-$79,890-$120,822
% Margin-68,327%-257,709.7%-80,014.6%